Agios Pharmaceuticals, Inc.【AGIO】 研究開発費の推移

機能の使い方
(単位:千ドル) 研究開発費 前年比(%)
2Q25 91,940 +18.8%
1Q25 72,743 +6.0%
3Q24 72,455 -11.5%
2Q24 77,401 +12.3%
1Q24 68,620 +2.0%
3Q23 81,841 +26.0%
2Q23 68,895 -7.6%
1Q23 67,301 -4.0%
3Q22 64,966 +1.5%
2Q22 74,523 +20.2%
1Q22 70,123 +21.6%
3Q21 64,000 -28.5%
2Q21 62,007 -31.8%
1Q21 57,667 -36.8%
3Q20 89,555 -11.9%
2Q20 90,917 -15.3%
1Q20 91,256 -4.5%
3Q19 101,672 +23.1%
2Q19 107,389 +23.8%
1Q19 95,585 +22.2%
3Q18 82,561 +13.2%
2Q18 86,730 +8.7%
1Q18 78,224 +24.7%
3Q17 72,917 +20.2%
2Q17 79,816 +57.1%
1Q17 62,732 +42.4%
3Q16 60,643 +68.3%
2Q16 50,804 +39.5%
1Q16 44,038 +35.7%
3Q15 36,028 +41.1%
2Q15 36,423 +61.3%
1Q15 32,443 +86.4%
3Q14 25,526 +72.4%
2Q14 22,576 +74.2%
1Q14 17,407 -
3Q13 14,803 -
2Q13 12,958 -